Transcription factor LSF: a mitotic regulator in hepatocellular carcinoma cells
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Current treatments are subpar, with late stage diagnosis and poor prognosis contributing to limited treatment options. The evolutionarily conserved, ubiquitously expressed transcription factor LSF is overexpres...
Main Author: | Willoughby, Jennifer Lynn Sherman |
---|---|
Language: | en_US |
Published: |
2017
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/20713 |
Similar Items
-
Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence
by: Jennifer L. S. Willoughby, et al.
Published: (2020-06-01) -
Transcription factor LSF: interactions with protein partners leading to epigenetic regulation and microtubule modifications
by: Chin, Hang Gyeong
Published: (2020) -
The anti-cancer compound, Factor Quinolinone Inhibitor 1, inhibits stable kinetochore-microtubule attachment during mitotic progression
by: Yunes, Sarah Ann
Published: (2020) -
Mapping the YY1 and p65 binding sites on the transcription factor LSF
by: Church, William David
Published: (2016) -
Moonlighting in Mitosis: Analysis of the Mitotic Functions of Transcription and Splicing Factors
by: Maria Patrizia Somma, et al.
Published: (2020-06-01)